0001236030-23-000013.txt : 20230810 0001236030-23-000013.hdr.sgml : 20230810 20230810165002 ACCESSION NUMBER: 0001236030-23-000013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230808 FILED AS OF DATE: 20230810 DATE AS OF CHANGE: 20230810 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Watson Robert Eugene CENTRAL INDEX KEY: 0001511858 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11889 FILM NUMBER: 231160359 MAIL ADDRESS: STREET 1: 245 N. HIGHLAND AVE NE STREET 2: SUITE 230-296 CITY: ATLANTA STATE: GA ZIP: 30307 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEL SCI CORP CENTRAL INDEX KEY: 0000725363 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 840916344 STATE OF INCORPORATION: CO FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 8229 BOONE BLVD . STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 BUSINESS PHONE: 7035069460 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD. STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 FORMER COMPANY: FORMER CONFORMED NAME: INTERLEUKIN 2 INC DATE OF NAME CHANGE: 19880317 4 1 primary_doc.xml PRIMARY DOCUMENT X0508 4 2023-08-08 0 0000725363 CEL SCI CORP CVM 0001511858 Watson Robert Eugene 245 N. HIGHLAND AVE NE SUITE 230-296 ATLANTA GA 30307 1 0 0 0 0 Options 1.36 2023-08-08 4 A 0 64000 0.01 A 2033-08-07 Common Stock 64000 634000 D The stock options vest in three (3) equal annual installments commencing one year after the grant date. Robert Watson 2023-08-10